VCRE Stock Price & Analysis (NASDAQ)

$11.01

USD

0.50(-4.34%)

At close: Sep 11, 14:04 EDT

Company Profile

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

CEOAhmed Mousa

SectorHealthcare

IndustryBiotechnology

Employees37

IPO Date

Recently from Cashu

Jul 2, 2026

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

AddressKornhamnstorg 53

City / State / ZIPStockholm, AB, 111 27

CountrySweden

Websitehttps://vicorepharma.com